Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-05362-x ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Christopher Connors und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. christopher.connors@icahn.mssm.edu. Hauptthemen laut MEDLINE: Databases, Factual, Ureteral Neoplasms, Carcinoma, Squamous Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: We sought to investigate the disease characteristics, treatment patterns, and survival outcomes of upper urinary tract squamous cell carcinoma (UT-SCC) using the National Cancer Database (NCDB). METHODS: The NCDB was queried for UT-SCC patients from 2004 to 2020. Patients with upper tract urothelial carcinoma (UTUC) were also identified for comparison with UT-SCC. Baseline characteristics were compared between UT-SCC and UTUC patients. Kaplan-Meier analysis assessed stage-based differences in median overall survival (mOS) between 1:4 propensity-matched cohorts of UT-SCC and UTUC patients. Predictors of mortality were assessed via multivariate cox regression. RESULTS: 644 cases of UT-SCC and 55,994 cases of UTUC were identified. Compared to UTUC, UT-SCC patients were more likely to have a higher TNM stage, lymphovascular invasion, and positive surgical margins. UT-SCC demonstrated a comparable mOS to UTUC for non-metastatic T1-T2 disease (74.84 vs. 106.38 months, p = 0.353) and metastatic disease (5.62 vs. 7.16 months, p = 0.058). However, UT-SCC carried a poorer prognosis for carcinoma in situ (45.14 vs. 69.32 months, p = 0.032) and non-metastatic T3-T4 disease (13.63 vs. 31.93 months, p < 0.001). Moreover, we found increasing T stage, metastatic disease, and positive surgical margins to be significant predictors of UT-SCC mortality. Lastly, we found that surgery does not confer a survival benefit over other management strategies for metastatic UT-SCC. CONCLUSIONS: UT-SCC is a rare, aggressive malignancy that typically presents with a more advanced stage than UTUC. Surgical margin status may represent one of the most salient predictors of UT-SCC mortality. Further studies are needed to best define treatment strategy for this uncommon malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. christopher.connors@icahn.mssm.edu.
- Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Zitieren
APA
Connors, C., Omidele, O., Tomer, N., Levy, M., Mehrazin, R., Badani, K., & Sfakianos, J. P. (2024). Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database. World Journal of Urology. https://doi.org/10.1007/s00345-024-05362-x
Vancouver
Connors C, Omidele O, Tomer N, Levy M, Mehrazin R, Badani K, et al. Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database. World Journal of Urology. 2024. doi:10.1007/s00345-024-05362-x
BibTeX
@article{Connors2024,
author = {Connors, Christopher and Omidele, Olamide and Tomer, Nir and Levy, Micah and Mehrazin, Reza and Badani, Ketan and Sfakianos, John P},
title = {Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-05362-x}
}
EUVIMED